skip to content

Wellcome Trust - Cambridge Centre for Global Health Research

(Closed)
 

Flu breaking out of an infected cellMicrobes are highly adaptive and can evolve rapidly, acquiring new virulence traits or evolving resistance to therapeutic drugs. Pathogens such as Ebola Virus can move from zoonotic sources into the human population, causing epidemic disease and challenging health care systems. The Centre’s focus on pathogen evolution makes these challenges a central component of our research efforts.

We have experts working on emerging pathogens, in both a veterinary and human context and we work closely with sites in the field using molecular surveillence as a key tool. The emergence and spread of antimicrobial resistance (AMR) poses a particular challenge.  Indeed AMR has been identified as a major threat to human health by the UK Chief Medical Officer and several of our groups work in this area. Find links to some of our programmes in these areas below.

Tuberculosis

Vaccines

Virus Research

Genotype to Phenotype Research

 

Image: Flu virus released from an infected cell. Credit: David Goulding, Wellcome Trust Sanger Institute

 

AMR Review

The Review was established to produce analysis of the global problems of antimicrobial resistance (AMR), and  to propose concrete actions to tackle these internationally.

None

UoC_WT-CCGHR_RGB_hi.jpg

The Cambridge Centre for Global Health Research is funded by the Wellcome Trust. In close collaboration with The Wellcome Trust Sanger Institute, it supports researchers working in public health and tropical medicine to develop their careers, and foster interchange between institutions in the UK and those based in low- and middle-income countries.

Mini transparent wtccghr logo

 

The Centre supports collaborative partnerships and scientific training activities in basic biomedical and health-related research. This is achieved through coordinated cross-faculty research across departments and research institutes in Cambridge including The Wellcome Trust Sanger Institute

Follow us on Twitter